Abnormal anandamide metabolism in celiac disease

Journal of Nutritional Biochemistry

Volumn 23, Issue 10, 2012, Pages 1245-1248

  Battista, Natalia ^a   Di Sabatino, Antonio ^b   Di Tommaso, Monia ^a   Biancheri, Paolo ^b   Rapino, Cinzia ^a   Vidali, Francesca ^b   Papadia, Cinzia ^c   Montana, Chiara ^c   Pasini, Alessandra ^b   Lanzini, Alberto ^d   Villanacci, Vincenzo ^d   Corazza, Gino R ^b   Maccarrone, Mauro ^a,e  

^a UNIVERSITY OF TERAMO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY HOSPITAL OF PARMA   (Italy)

^d SPEDALI CIVILI   (Italy)

^e IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Duodenal mucosa; Endocannabinoid; FAAH; Gliadin; NAPE PLD

Indexed keywords

ANANDAMIDE;

ADULT; ARTICLE; CELIAC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DUODENUM MUCOSA; ENZYME ACTIVITY; EX VIVO STUDY; FEMALE; GLUTEN FREE DIET; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IN VIVO STUDY; MALE; METABOLIC DISORDER; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AMIDOHYDROLASES; ARACHIDONIC ACIDS; BIOPSY; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELIAC DISEASE; DIET, GLUTEN-FREE; DUODENUM; ENDOCANNABINOIDS; FEMALE; GLIADIN; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PHOSPHOLIPASE D; POLYUNSATURATED ALKAMIDES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION; YOUNG ADULT;

EID: 84866323598     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.06.017     Document Type: Article

References (22)

1. Muccioli G.G. Endocannabinoid biosynthesis and inactivation, from simple to complex. Drug Discov Today 2010, 15:474-483.
2. Petrosino S., Ligresti A., Di Marzo V. Endocannabinoid chemical biology: a tool for the development of novel therapies. Curr Opin Chem Biol 2009, 13:309-320.
3. Izzo A.A., Camilleri M. Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects. Gut 2008, 57:1140-1155.
4. Tanasescu R., Constantinescu C.S. Cannabinoids and the immune system: an overview. Immunobiology 2010, 215:588-597.
5. Klein T.W. Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat Rev Immunol 2005, 5:400-411.
6. Croxford J.L., Yamamura T. Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?. J Neuroimmunol 2005, 166:3-18.
7. Izzo A.A., Sharkey K.A. Cannabinoids and the gut: new developments and emerging concepts. Pharmacol Ther 2010, 126:21-38.
8. Di Sabatino A., Battista N., Biancheri P., Rapino C., Rovedatti L., Astarita G., et al. A key role for the endogenous cannabinoid system in the gut mucosa of inflammatory bowel disease patients. Mucosal Immunol 2011, 4:574-583.
9. Di Sabatino A., Corazza G.R. Celiac disease. Lancet 2009, 373:1480-1493.
10. D'Argenio G., Petrosino S., Gianfrani C., Valenti M., Scaglione G., Grandone I., et al. Overactivity of the intestinal endocannabinoid system in celiac disease and in methotrexate-treated rats. J Mol Med 2007, 85:523-530.
11. Ueda N., Tsuboi K., Uyama T. Enzymological studies on the biosynthesis of N-acylethanolamines. Biochim Biophys Acta 2010, 1801:1274-1285.
12. Fezza F., De Simone C., Amadio D., Maccarrone M. Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system. Subcell Biochem 2008, 49:101-132.
13. Di Sabatino A., Pickard K.M., Gordon J.N., Salvati V., Mazzarella G., Beattie R.M., et al. Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease. Gastroenterology 2007, 133:1175-1187.
14. Okamoto Y., Morishita J., Tsuboi K., Tonai T., Ueda N. Molecular characterization of a phospholipase D generating anandamide and its congeners. J Biol Chem 2004, 279:5298-5305.
15. Fezza F., Gasperi V., Mazzei C., Maccarrone M. Radiochromatographic assay of N-acyl-phosphatidylethanolamine-specific phospholipase D activity. Anal Biochem 2005, 339:113-120.
16. Fegley D., Gaetani S., Duranti A., Tontini A., Mor M., Tarzia G., et al. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. J Pharmacol Exp Ther 2005, 313:352-358.
17. Di Sabatino A., Jackson C.L., Pickard K.M., Buckley M., Rovedatti L., Leakey N.A.B., et al. Transforming growth factor-β signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures. Gut 2009, 58:777-789.
18. Kunos G., Pacher P. Cannabinoids cool the intestine. Nat Med 2004, 10:678-679.
19. Smid S.D. Gastrointestinal endocannabinoid system: multifaceted roles in the healthy and inflamed intestine. Clin Exp Pharmacol Physiol 2008, 35:1383-1387.
20. Massa F., Marsicano G., Hermann H., Cannich A., Monory K., Cravatt B.F., et al. The endogenous cannabinoid system protects against colonic inflammation. J Clin Invest 2004, 113:1202-1209.
21. Simon G.M., Cravatt B.F. Characterization of mice lacking candidate N-acyl ethanolamine biosynthetic enzymes provides evidence for multiple pathways that contribute to endocannabinoid production in vivo. Mol Biosyst 2010, 6:1411-1418.
22. MacDonald T.T., Monteleone G. Immunity, inflammation, and allergy in the gut. Science 2005, 307:1920-1925.